Amanta Healthcare IPO Subscription Status
Amanta Healthcare IPO subscribed over 4.62x on its first day till 5.00 PM on 1st September 2025.
- Amanta Healthcare IPO subscription QIB investors’ portion was 0.04 times, while NII subscribers subscribed 5.82 times, and RII investors subscribed 6.72 times.
- The company has received bids for 3,23,16,354 shares against 70,00,000 on offer for the first-day subscription.
- Amanta Healthcare IPO subscribed over 4.62x on its day 1.
About Amanta Healthcare Company
Amanta Healthcare Limited, founded in December 1994, is one of the leading pharmaceutical companies that is involved in the development, manufacturing, and marketing of a wide range of sterile liquid products, mainly parenterals. These are packed in plastic containers using advanced Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. IV fluids, diluents, eye drops, and respiratory care solutions are some of the fluid therapy products that the company makes.
Amanta Healthcare also produces irrigation solutions, first-aid items, and eye lubricants under its medical devices segment. The company markets its products through three business divisions: National Sales, International Sales, and Product Partnerships with various Indian and foreign pharmaceutical companies. Under its own brand, the company makes over 45 generic products and sells them in India, through 320 distributors and stockists. The company employs a total of 1,718 employees as of March 31, 2025.
Amanta Healthcare Financial Report
The company reported revenue of ₹276 crores in 2025 against ₹282 crores in 2024. The company reported a profit of ₹10.50 crores in 2025 against a profit of ₹3.63 crores in 2024.
Amanta Healthcare IPO GMP:
Amanta Healthcare IPO GMP was ₹29 as of Monday, 1st September. That indicates the IPO is trading at ₹155 with a ₹29 premium in the grey market against the issue price of ₹126.
